Physician profile
Eric P Cote
NPI 1669435558
$14,758.23
in general payments reported to CMS, 2019-2025
55 companies · $2,616 in 2025
The $2,616 reported for 2025 was more than what 85% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,269 · 2020: $1,007 · 2021: $1,637 · 2022: $2,275 · 2023: $2,217 · 2024: $2,738 · 2025: $2,616.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,571.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,571.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $1,796.08 | 2019-2025 | Provenge |
| Abbvie INC. | $1,283.96 | 2020-2025 | Botox, Lupron Depot |
| Boston Scientific Corporation | $1,215.38 | 2019-2025 | Advance Xp, Rezum Generator, Lumenis Pulse 120h |
| Janssen Biotech, INC. | $1,014.26 | 2019-2025 | Erleada, Akeega |
| Astellas Pharma US INC | $1,011.73 | 2019-2025 | Xtandi, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $985.83 | 2019-2025 | |
| Pfizer INC. | $983.34 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $670.41 | 2019-2024 | Xiaflex, Aveed, Edex |
| Blue Earth Diagnostics | $667.63 | 2019-2025 | Posluma |
| Sumitomo Pharma America, INC. | $624.99 | 2023-2025 | Orgovyx, Gemtesa |
| Endo USA, INC. | $570.94 | 2024-2025 | Xiaflex, Aveed |
| Antares Pharma, INC. | $362.97 | 2019-2024 | Xyosted, Nocdurna, Tlando |
| Progenics Pharmaceuticals, INC. | $349.92 | 2024-2025 | |
| Axonics, INC. | $324.31 | 2021-2024 | Axonics |
| Urogen Pharma, INC. | $253.95 | 2020-2025 | Jelmyto |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $174.88 | 2021-2022 | |
| Amgen INC. | $170.70 | 2019-2023 | Prolia |
| Calyxo, INC. | $165.99 | 2024-2025 | Cvac Aspiration System |
| Novartis Pharmaceuticals Corporation | $147.41 | 2023-2025 | |
| Medtronic, INC. | $130.72 | 2021 | |
| Merck Sharp & Dohme LLC | $129.48 | 2020-2024 | Keytruda, Welireg, Lynparza |
| Urovant Sciences INC | $124.95 | 2022 | |
| Accord Healthcare, INC. | $114.97 | 2022-2025 | |
| Rochester Medical Corporation | $106.06 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $105.90 | 2019-2024 | Yonsa |
| Ferring Pharmaceuticals INC. | $105.34 | 2019-2025 | Adstiladrin |
| Intuitive Surgical, INC. | $89.00 | 2019-2022 | |
| Tempus Ai, INC | $81.20 | 2024-2025 | Xt Cdx |
| Olympus America INC. | $76.69 | 2025 | Itind System |
| Astrazeneca Pharmaceuticals Lp | $72.97 | 2021-2023 | Lynparza |
| Neotract INC. | $71.87 | 2020 | |
| Photocure INC | $62.13 | 2019-2021 | |
| Ambu INC. | $61.10 | 2022-2023 | |
| Bard Access Systems, INC. | $56.83 | 2019 | |
| Davol INC. | $47.39 | 2023 | Arista Ah Flexitip |
| Travere Therapeutics, INC. | $47.32 | 2020-2022 | |
| Inspire Medical Systems, INC. | $47.02 | 2025 | Inspire |
| Procept Biorobotics Corporation | $46.42 | 2023-2024 | Aquabeam Robotic System, Aquabeam System |
| Allergan, INC. | $42.86 | 2019-2020 | |
| Ethicon US, LLC | $42.85 | 2021-2023 | Echelon Flex |
| Teleflex LLC | $39.40 | 2020-2023 | Urolift |
| Cook Medical LLC | $35.78 | 2024-2025 | Litho 150, Resonance |
| Janssen Scientific Affairs, LLC | $27.71 | 2019 | |
| Clarus Therapeutics INC. | $25.04 | 2021 | |
| Myriad Genetic Laboratories, INC. | $22.91 | 2021 | |
| Abc Home Medical Supply, INC. | $22.88 | 2025 | |
| Genzyme Corporation | $21.83 | 2023 | |
| Immunitybio, INC. | $19.51 | 2024 | |
| Laborie Medical Technologies Corp. | $18.24 | 2024 | Endosheath Technology |
| Foundation Medicine, INC. | $16.67 | 2022 | |
| Halozyme INC | $16.61 | 2023 | |
| Baxter Healthcare | $14.84 | 2019 | |
| Therapeuticsmd, INC. | $14.00 | 2019 | |
| Tolmar, INC. | $13.68 | 2025 | Eligard |
| C. R. Bard, INC. & Subsidiaries | $11.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Cote listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.